Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephan Seitz

Showing results (21-30 of 56) with videos related to

Pageof 6
Sort By:
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH)Stefan Buchholz, Stephan Seitz, Jörg B Engel, et al.
Frontiers in Immunology|May 14, 2024
Neoadjuvant radiotherapy in ER<sup>+</sup>, HER2<sup>+</sup>, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacyChristina Bruss, Veruschka Albert, Stephan Seitz, et al.
Archives of Gynecology and Obstetrics|August 26, 2025
Chemotherapy in elderly patients with early breast cancer: a systematic reviewMiriam Fernández-Pacheco, Michael Gerken, Atanas Ignatov, et al.
The Breast Journal|April 8, 2026
Treatment Regimens and Response Rates in Early TNBC: A Review of Real-World Practice in the Second Decade of the 21st CenturyMaria Eleni Hatzipanagiotou, Verena Tannert, Michael Gerken, et al.
Journal of Clinical Medicine|January 10, 2026
Locoregional Breast Cancer Recurrences After Ablatio Mammae and Primary ReconstructionConstance Valette, Alexandra Anker, Michael Gerken, et al.
Archives of Gynecology and Obstetrics|December 12, 2022
Automated breast ultrasound (ABUS) for intraoperative margin control on surgical specimens in breast conserving surgeryMaria Eleni Hatzipanagiotou, Deborah Huber, Elisa Thede, et al.
International Journal of Molecular Sciences|July 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor MiceVeruschka Albert, Christina Bruss, Deniz Tümen, et al.
Archives of Gynecology and Obstetrics|October 15, 2021
Correction to: New aspects in digital breast assessment: further refinement of a method for automated digital anthropometryRobin Hartmann, Maximilian Weiherer, Daniel Schiltz, et al.
Archives of Gynecology and Obstetrics|November 13, 2020
New aspects in digital breast assessment: further refinement of a method for automated digital anthropometryRobin Hartmann, Maximilian Weiherer, Daniel Schiltz, et al.
Breast Cancer Research and Treatment|July 17, 2008
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibitionFrank Köster, Jörg B Engel, Andrew V Schally, et al.
Pageof 6

Showing results (21-30 of 56) with videos related to

Sort By:
Pageof 6
Hormone Molecular Biology and Clinical Investigation|May 12, 2015
Search for novel therapies for triple negative breast cancers (TNBC): analogs of luteinizing hormone-releasing hormone (LHRH) and growth hormone-releasing hormone (GHRH)Stefan Buchholz, Stephan Seitz, Jörg B Engel, et al.
Frontiers in Immunology|May 14, 2024
Neoadjuvant radiotherapy in ER<sup>+</sup>, HER2<sup>+</sup>, and triple-negative -specific breast cancer based humanized tumor mice enhances anti-PD-L1 treatment efficacyChristina Bruss, Veruschka Albert, Stephan Seitz, et al.
Archives of Gynecology and Obstetrics|August 26, 2025
Chemotherapy in elderly patients with early breast cancer: a systematic reviewMiriam Fernández-Pacheco, Michael Gerken, Atanas Ignatov, et al.
The Breast Journal|April 8, 2026
Treatment Regimens and Response Rates in Early TNBC: A Review of Real-World Practice in the Second Decade of the 21st CenturyMaria Eleni Hatzipanagiotou, Verena Tannert, Michael Gerken, et al.
Journal of Clinical Medicine|January 10, 2026
Locoregional Breast Cancer Recurrences After Ablatio Mammae and Primary ReconstructionConstance Valette, Alexandra Anker, Michael Gerken, et al.
Archives of Gynecology and Obstetrics|December 12, 2022
Automated breast ultrasound (ABUS) for intraoperative margin control on surgical specimens in breast conserving surgeryMaria Eleni Hatzipanagiotou, Deborah Huber, Elisa Thede, et al.
International Journal of Molecular Sciences|July 13, 2024
HER4 Affects Sensitivity to Tamoxifen and Abemaciclib in Luminal Breast Cancer Cells and Restricts Tumor Growth in MCF-7-Based Humanized Tumor MiceVeruschka Albert, Christina Bruss, Deniz Tümen, et al.
Archives of Gynecology and Obstetrics|October 15, 2021
Correction to: New aspects in digital breast assessment: further refinement of a method for automated digital anthropometryRobin Hartmann, Maximilian Weiherer, Daniel Schiltz, et al.
Archives of Gynecology and Obstetrics|November 13, 2020
New aspects in digital breast assessment: further refinement of a method for automated digital anthropometryRobin Hartmann, Maximilian Weiherer, Daniel Schiltz, et al.
Breast Cancer Research and Treatment|July 17, 2008
Triple-negative breast cancers express receptors for growth hormone-releasing hormone (GHRH) and respond to GHRH antagonists with growth inhibitionFrank Köster, Jörg B Engel, Andrew V Schally, et al.
Pageof 6